Iterum Therapeutics PLC (ITRM) support and resistance · rev $390.0K
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
This page maps Iterum Therapeutics PLC (ITRM) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
ITRM currently screens at market cap $38.6M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new ITRM 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the ITRM quote page for the session range and the stock page for the full model.
Not investment advice.